Source: Annual Congress 2007 - Lung neoplasms
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kanbay, S. Demirtas, I. K. Oguzulgen, O. Kokturk, O. Gulbahar, N. Bukan (Ankara, Turkey). Can VEGF be used in differential diagnosis of pleural effusions?. Eur Respir J 2007; 30: Suppl. 51, 3366

Member's Comments

No comment yet.

Related content which might interest you: Pleural fluid leptin level for the differential diagnosis of pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Is pleural VEGF a useful parameter? Source: Annual Congress 2007 - Pleural malignancy Year: 2007 Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid Source: Eur Respir J 2006; 28: Suppl. 50, 455s Year: 2006 Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 The value of adenosin-deaminase in etiologic diagnosis of pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 167s Year: 2002 Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Is ²blind² pleural biopsy still of value in tuberculous effusions? Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives Year: 2008 Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Pleural fluid interleukin-10 level in the diagnosis of tuberculous effusions Source: Eur Respir J 2002; 20: Suppl. 38, 581s Year: 2002 The Role of PET-CT in differential diagnosis of malignant-paramalignant pleural effusion Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018 Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 Diagnostic value of IL-8 in differentiating between exudative and transudative pleural effusion Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 The diagnostic usefulness of MAGE expression in the diagnosis of exudative pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004 Malignant pleural effusions: diagnosis and management Source: International Congress 2017 – PG5 Pleural disease management Year: 2017 The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions Source: Annual Congress 2009 - Pleural diseases Year: 2009